标题：Influencia epigenómica de la actividad / inactividad física en el origen de la Diabetes mellitus tipo 2. (Epigenomic influence of the physical activity/inactivity in the origin of type 2 diabetes).
期刊名称：RICYDE. Revista Internacional de Ciencias del Deporte. doi:10.5232/ricyde
印刷版ISSN：1885-3137
出版年度：2009
卷号：5
期号：16
页码：1-20
语种：Spanish
出版社：Ramón Cantó Alcaraz (Publisher)
摘要：Contrariamente al modelo centrado en las mutaciones, el cual asume que alteraciones en la función son consecuencia de mutaciones somáticas o heredadas en la secuencia del DNA, el modelo epigenético implica una carencia de regulación de uno o más genes. Un componente crítico del epigenoma son los patrones de distribución de las citosinas metiladas en secuencias de dinucleótidos CpG. Tal metilación marca los genes para su inactivación al interferir con la unión de factores de transcripción sensibles a DNA metilado o bien al reclutar proteínas que agrupan complejos correpresores y deacetilasas de histonas en torno a la cromatina. Estas marcas epigenéticas son propagadas luego mitótica y en algunos casos meióticamente, resultando en una herencia estable de estados regulatorios. Hoy se sabe que la dieta u otros factores ambientales son un punto de control para la regulación de la expresión génica y que durante periodos críticos de desarrollo, la cromatina sería particularmente sensible a modificaciones epigenómicas. De esta manera una explicación epigenómica del origen fetal de las enfermedades crónicas del adulto parece razonable. La presente revisión explica cómo la actividad/inactividad física de la madre o de la progenie en etapas tempranas, puede predisponer a Diabetes mellitus tipo 2 en la vida adulta a través de este mecanismo. Palabras clave : diabetes; epigenética; inactividad física. Abstract Contrary to the model centered in the mutations, which assumes that alterations in the function are consequence of somatic or inherited mutations in the sequence of the DNA, the epigenetic model implies dysregulation of one or more genes. A critical component of epigenome is its distribution patterns of the methylated cytosines in CpG sequences. This methylation marks to genes for their inactivation interfering with the union of methylated DNA-sensible transcription factors or recruiting proteins that group corepressor complexes and histone deacetylases around of chromatin. These epigenetic marks are propagated soon mitotic and in some cases meioticaly, result in a stable inheritance of regulatory states. Today it is known that diet or other environmental factors are a control point for the regulation of the gene expression and that during critical periods of development, the chromatin would be particularly sensible to epigenomics modifications. This way, an epigenomic explanation of the fetal origin of adult´s chronic diseases seems reasonable. The present review explains how physical activity/inactivity of the mother or the lineage in early stages can ready to Diabetes mellitus type 2 in the adult life through this mechanism. Key words : diabetes; epigenetic; physical inactivity. doi:10.5232/ricyde2009.01601 Texto completo en PDF --------------------------------------------------------------------- Referencias/references Adair, L.S. & Prentice, A.M. (2004). A critical evaluation of the fetal origins hypothesis and its implications for developing countries. J Nutr, 134(1), 191-193. PMid:14704317 Adamo, K.B.; Sigal, R.J.; Williams, K.; Kenny, G.; Prud'homme, D. & Tesson, F. (2005). Influence of Pro12Ala peroxisome proliferator-activated receptor gamma2 polymorphism on glucose response to exercise training in type 2 diabetes. Diabetologia, 48(8), 1503-1509. doi:10.1007/s00125-005-1827-y PMid:15986237 American Diabetes Association. (2004). Diagnosis and Classification Of Diabetes Mellitus. Diabetes Care, 27, S5-S10. doi:10.2337/diacare.27.2007.S5 Baier, L.J.; Wiedrich, C.; Hanson, R.L.; Bogardus, C. (1998). Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85α): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes, 47: 973–975. doi:10.2337/diabetes.47.6.973 PMid:9604878 Barker, D.J. (2004). The developmental origins of adult disease. J Am Coll Nutr, 23(6 Suppl), 588S-595S. PMid:15640511 Barroso I. (2005). Genetics of Type 2 diabetes. Diabet Med, 22(5):517-35. doi:10.1111/j.1464-5491.2005.01550.x PMid:15842505 Bindon, J.; Baker, P. (1997). Bergmann’s Rule and the Thrifty Genotype. Am J Phys Anthropol, 104, 201-210. doi:10.1002/(SICI)1096-8644(199710)104:2<201::AID-AJPA6>3.0.CO;2-0 Booth, F.; Chakravarthy, M.; Gordon, S. & Spangenburg, E. (2002). Waging War On physical inactivity: using modern molecular ammunition against an ancient enemy. J Appl Physiol, 93, 3–30. PMid:12070181 Booth, F.; Gordon, S.; Carlson, C. & Hamilton, M. (2000). Waging war on modern chronic diseases: primary prevention through exercise biology. J. Appl. Physiol, 88, 774–787. PMid:10658050 Booth, F.W. & Lees, S.J. (2007). Fundamental questions about genes, inactivity, and chronic diseases. Physiol Genomics, 28(2), 146-157. doi:10.1152/physiolgenomics.00174.2006 PMid:17032813 Carulli, L.; Rondinella, S.; Lombardini, S.; Canedi, I; Loria, P. & Carulli, N. (2005). Diabetes, genetics and ethnicity. Aliment Pharmacol Ther, 22 (Suppl. 2), 16–19. doi:10.1111/j.1365-2036.2005.02588.x Chakravarthy, M. & Booth, F. (2004). Eating, exercise, and “thrifty” genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases. J Appl Physiol, 96, 3–10. doi:10.1152/japplphysiol.00757.2003 PMid:14660491 Cooney, C.A.; Dave, A.A. & Wolff, G.L. (2002). Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr, 132(8 Suppl), 2393S-2400S. PMid:12163699 Cordain, L.; Gotshall, R.W.; Eaton, S.B. & Eaton, S.B. III. (1998). Physical activity, energy expenditure and fitness: an evolutionary perspective. Int J Sports Med, 19, 328–335. doi:10.1055/s-2007-971926 PMid:9721056 Cushing, B.S. & Kramer, K.M. (2005). Mechanisms underlying epigenetic effects of early social experience: the role of neuropeptides and steroids. Neurosci Biobehav Rev, 29(7), 1089-1105. doi:10.1016/j.neubiorev.2005.04.001 Dabelea, D.; Hanson, R.L.; Lindsay, R.S.; Pettitt, D.J.; Imperatore, G.; Gabir, M.M.; Roumain, J.; Bennett, P.H. & Knowler, W.C. (2000). Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity. Diabetes, 49, 2208–2211. doi:10.2337/diabetes.49.12.2208 PMid:11118027 Deeb, S.S.; Fajas, L.; Nemoto, M.; Pihlajamaki, J.; Mykkanen, L.; Kuusisto, J.; Laakso, M.; Fujimoto, W. and Auwerx, J. (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet., 20, 284–287. doi:10.1038/3099 PMid:9806549 Doherty, A.S.; Mann, M.R.; Tremblay, K.D.; Bartolomei, M.S. & Schultz, R.M. (2000). Differential effects of culture on imprinted H19 expression in the preimplantation mouse embryo. Biol Reprod, 62(6), 1526-1535. doi:10.1095/biolreprod62.6.1526 PMid:10819752 Dolinoy, D.C.; Weidman, J.R. & Jirtle, R.L. (2007). Epigenetic gene regulation: Linking early developmental environment to adult disease. Reproductive Toxicology, 23, 297–307. doi:10.1016/j.reprotox.2006.08.012 PMid:17046196 Eaton, S.B.; Strassman, B.I.; Nesse, R.M.; Neel, J.V.; Ewald, P.W.; Williams, G.C.; Weder, A.B.; Eaton, S.B. III; Lindeberg, S.; Konner, M.J.; Mysterud, I. & Cordain, L. (2002). Evolutionary health promotion. Prev Med, 34, 109–118. doi:10.1006/pmed.2001.0876 PMid:11817903 Egeland, G.M.; Skjaerven, R. & Irgens, L.M. (2000). Birth characteristics of women who develop gestational diabetes: population based study. BMJ, 321(7260), 546-547. PMid:11793024 Ek, J.; Andersen, G.; Urhammer, S.A.; Gaede, P.H.; Drivsholm, T.; Borch-Johnsen, K.; Hansen, T.; Pedersen, O. (2001). Mutation analysis of peroxisome proliferatoractivated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia, 44: 2220–2226. doi:10.1007/s001250100032 PMid:1778354 Eriksson, K.F. & Lindgärde, F. (1991). Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia, 34(12), 891-898. doi:10.1007/BF00400196 Forcales, S. & Puri, P. (2005). Signaling to the chromatin during skeletal myogenesis: Novel targets for pharmacological modulation of gene expression. Semin Cell Dev Biol, 16596–16611. PMid:10906831 Forsen, T.; Eriksson, J.; Tuomilehto, J.; Reunanen, A.; Osmond, C. & Barker, D. (2000). The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med, 133(3), 176-182. PMid:15983188 Gallou-Kabani, C. & Junien, C. (2005). Nutricional epigenomics of metabolic syndrome. New perspective against the epidemic. Diabetes, 1899-1906. doi:10.2337/diabetes.54.7.1899 Garant, M.J.; Kao, W.H.; Brancati, F.; Coresh, J.; Rami, T.M.; Hanis, C.L.; Boerwinkle, E.; Shuldiner, A.R. (2002). Atherosclerosis Risk in Communities Study. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes, 51: 231–237. doi:10.2337/diabetes.51.1.231 Gloyn, A.L.; Weedon, M.N.; Owen, K.R.; Turner, M.J.; Knight, B.A.; Hitman, G.A.; Walker, M.; Levy, J.C.; Sampson, M.J.; Halford, S; McCarthy, M.I.; Hattersley, A.T.; Frayling, T.M. (2003) Large scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with increased risk of Type 2 Diabetes. Diabetes, 52, 568–572. doi:10.2337/diabetes.52.2.568 PMid:8541847 Gough, S.C.; Saker, P.J.; Pritchard, L.E.; Merriman, T.R.; Merriman, M.E.; Rowe, B.R.; Kumar, S.; Aitman, T.; Barnett, A.H.; Turner, R.C. (1995). Mutation of the glucagon receptor gene and diabetes mellitus in the UK: association or founder effect? Hum Mol Genet, 4: 1609–1612. doi:10.1093/hmg/4.9.1609 PMid:7773293 Hager, J.; Hansen, L.; Vaisse, C.; Vionnet, N.; Philippi, A.; Poller, W. (1995). A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet, 9: 299–304. doi:10.1038/ng0395-299 PMid:12107756 Hara, K.; Tobe, K.; Okada, T.; Kadowaki, H.; Akanuma, Y.; Ito, C.; Kimura, S.; Kadowaki, T. (2002). A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia, 45: 740–743. doi:10.1007/s00125-002-0803-z PMid:11017071 Horikawa, Y.; Oda, N.; Cox, N.J.; Li, X.; Orho-Melander, M.; Hara, M.; Hinokio, Y.; Lindner, T.H.; Mashima, H.; Schwarz, P.E.; del Bosque-Plata; L., Horikawa, Y.; Oda, Y.; Yoshiuchi, I.; Colilla, S.; Polonsky, K.S.; Wei, S.; Concannon, P.; Iwasaki, N.; Schulze, J.; Baier, L.J.; Bogardus, C.; Groop, L.; Boerwinkle, E.; Hanis, C.L.; Bell, G.I. (2000). Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet, 26: 163–175. doi:10.1038/79876 PMid:10752264 Jaquet, D.; Gaboriau, A.; Czernichow, P. & Levy-Marchal, C. (2000). Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab, 85(4), 1401-1406. doi:10.1210/jc.85.4.1401 PMid:12819898 Jellema, A.; Zeegers, M.P.; Feskens, E.J.; Dagnelie, P.C.; Mensink, R.P. (2003). Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies. Diabetologia, 46: 990–995. doi:10.1007/s00125-003-1126-4 PMid:12424509 Kaur, J.; Singh, P. & Sowers, J. (2002). Diabetes and Cardiovascular Diseases. Am J Ther, 9, 510–515. doi:10.1097/00045391-200211000-00009 PMid:15569624 Khan, A.U. & Krishnamurthy, S. (2005). Histone modifications as key regulators of transcription. Front Biosci, 1(10), 866-872. doi:10.2741/1580 PMid:17434282 Kim, H.; Lee, S.H.; Kim, S.S.; Yoo, J.H. & Kim, C.J. (2007). The influence of maternal treadmill running during pregnancy on short-term memory and hippocampal cell survival in rat pups. Int J Dev Neurosci, 25(4), 243-249. doi:10.1016/j.ijdevneu.2007.03.003 PMid:15562396 Kim, K.S.; Choi, S.M.; Shin, S.U.; Yang, H.S. & Yoon, Y. (2004). Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala polymorphism on body fat distribution in female Korean subjects. Metabolism, 53(12), 1538-1543. doi:10.1016/j.metabol.2004.06.019 PMid:11832527 PMCid:1370926 Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A. & Nathan, D.M. (2002). Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med, 346(6), 393-403. doi:10.1056/NEJMoa012512 PMid:15649575 Kosaka, K.; Noda, M. & Kuzuya, T. (2005). Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract, 67(2), 152-162. doi:10.1016/j.diabres.2004.06.010 PMid:12882479 Kriska, A. (2003). Can a Physically active lifestyle prevent type 2 diabetes?. Exerc Sport Sci Rev, 31(3), 132-137. doi:10.1097/00003677-200307000-00006 PMid:16368211 Lee, H.H.; Kim, H.; Lee, J.W.; Kim, Y.S.; Yang, H.Y.; Chang, H.K.; Lee, T.H.; Shin, M.C.; Lee, M.H.; Shin, M.S.; Park, S.; Baek, S. & Kim, C.J. (2006). Maternal swimming during pregnancy enhances short-term memory and neurogenesis in the hippocampus of rat pups. Brain Dev, 28(3), 147-154. doi:10.1016/j.braindev.2005.05.007 PMid:12145174 Lindi, V.; Uusitupa, M.; Lindström, J.; Louheranta, A.; Erickson, J.; Valle, T.; Hämäläinem, H.; Ilanne-Parikka, P.; Keinänem-Kiukaanniemi, S.; Laakso, M. & Tuomiletho, J. for the Finnish Diabetes Prevention Study Group. (2002). Association Of The Pro12Ala Polymorphism In The PPAR-g2 Gene Whit 3-Year Incidence Of Type 2 Diabetes And Body Weight Change In The Finnish Diabetes Prevention Study. Diabetes, 51, 2581-2586. doi:10.2337/diabetes.51.8.2581 Lindstrom, J.; Ilanne-Parikka, P.; Peltonen, M.; Aunola, S.; Eriksson, J.G.; Hemio, K.; Hamalainen, H.; Harkonen, P.; Keinanen-Kiukaanniemi, S.; Laakso, M.; Louheranta, A.; Mannelin, M.; Paturi, M.; Sundvall, J.; Valle, T.T.; Uusitupa, M. & Tuomilehto, J. (2006). Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet, 368(9548), 1673-1679. doi:10.1016/S0140-6736(06)69701-8 PMid:16759313 Mager, U.; Lindi, V.; Lindstrom, J.; Eriksson, J.G.; Valle, T.T.; Hamalainen, H.; Ilanne-Parikka, P.; Keinanen-Kiukaanniemi, S.; Tuomilehto, J.; Laakso, M.; Pulkkinen, L. & Uusitupa, M. Finnish Diabetes Prevention Study Group. (2006). Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study. Diabet Med, 23(6), 685-689. doi:10.1111/j.1464-5491.2006.01870.x PMid:12163708 Maier, S. & Olek, A. (2002). Diabetes: A Candidate Disease for Efficient DNA Methylation Profiling. J Nutr, 132, 2440S-2443S. PMid:15955369 Malecki, M. (2005). Genetics of type 2 diabetes mellitus. Diabetes Res Clin Pract, 68(S1), S10-S21. doi:10.1016/j.diabres.2005.03.003 Maynard Smith, J. (1990). Models of a dual inheritance system. J Theor Biol, 143(1), 41-53. doi:10.1016/S0022-5193(05)80287-5 PMid:11854095 McCarthy, M. (2002). Susceptibility gene discovery for common metabolic and endocrine traits. J Mol Endocrinol, 28, 1-17. doi:10.1677/jme.0.0280001 PMid:14722160 McCarthy, M. (2004). Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification. Hum Mol Genet, 13(Spec N°1), R33-R41. doi:10.1093/hmg/ddh057 PMid:16620308 McGee, S.L. (2006). Hargreaves M. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms. Clin Exp Pharmacol Physiol, 33(4), 395-399. doi:10.1111/j.1440-1681.2006.04362.x PMid:15180970 McKenzie, J.A.; Weiss, E.P.; Ghiu, I.A.; Kulaputana, O.; Phares, D.A.; Ferrell, R.E. & Hagberg, J.M. (2004). Influence of the interleukin-6 -174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indexes. J Appl Physiol, 97(4), 1338-1342. doi:10.1152/japplphysiol.00199.2004 Neel, J.V. (1962). Diabetes mellitus a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet, 14, 352-353. PMid:10968815 PMCid:27469 Pan, X.R.; Li, G.W.; Hu, Y.H.; Wang, J.X.; Yang, W.Y.; An, Z.X.; Hu, Z.X.; Lin, J.; Xiao, J.Z.; Cao, H.B.; Liu, P.A.; Jiang, X.G.; Jiang, Y.Y.; Wang, J.P.; Zheng, H.; Zhang, H.; Bennett, P.H. & Howard, B.V. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 20(4), 537-544. doi:10.2337/diacare.20.4.537 PMid:9096977 Parnpiansil, P.; Jutapakdeegul, N.; Chentanez, T. & Kotchabhakdi, N. (2003). Exercise during pregnancy increases hippocampal brain-derived neurotrophic factor mRNA expression and spatial learning in neonatal rat pup. Neurosci Lett, 352(1), 45-48. doi:10.1016/j.neulet.2003.08.023 PMid:14615046 Permutt, A.; Wasson, J. & Cox, N. (2005). Genetic epidemiology of diabetes. J Clin Invest, 115, 1431-1439. doi:10.1172/JCI24758 PMid:15931378 PMCid:1137004 Poirier, L.A.; Brown, A.T.; Fink, L.M.; Wise, C.K. & Randolph, C.J. (2001). Delongchamp RR, Fonseca VA. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism, 50, 1014–1018. doi:10.1053/meta.2001.25655 PMid:11555831 Ramachandran, A.; Snehalatha, C.; Mary, S.; Mukesh, B.; Bhaskar, A.D. & Vijay, V. (2006). Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia, 49(2), 289-297. doi:10.1007/s00125-005-0097-z PMid:16391903 Reik, W.; Römer, I.; Barton, S.C.; Surani, M.A.; Howlett, S.K. & Klose, J. (1993). Adult phenotype in the mouse can be affected by epigenetic events in the early embryo. Development, 119(3), 933-942. PMid:8187648 Simmons, R. (2005). Developmental origins of adult metabolic disease: concepts and controversies. Trends Endocrinol Metab, 16(8), 390-394. doi:10.1016/j.tem.2005.08.004 PMid:16118054 Sladek, R.; Rocheleau, G.; Rung, J.; Dina, C.; Shen, L.; Serre, D.; Boutin, P.; Vincent, D.; Belisle, A.; Hadjadj, S.; Balkau, B.; Heude, B.; Charpentier, G.; Hudson, T.J.; Montpetit, A.; Pshezhetsky, A.V.; Prentki, M.; Posner, B.I.; Balding, D.J.; Meyre, D.; Polychronakos, C. & Froguel, P. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature, 445, 881-885. doi:10.1038/nature05616 PMid:17293876 Sng, J.C.; Taniura, H. & Yoneda, Y. (2004). A Tale of Early Response Genes. Biol Pharm Bull, 27(5), 606-612. doi:10.1248/bpb.27.606 Sreekumar, R.; Halvatsiotis, P.; Schimke, J.C. & Nair, K.S. (2002). Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment. Diabetes, 51, 1913-1920. doi:10.2337/diabetes.51.6.1913 PMid:12031981 Valdez, R.; Athens, M.A.; Thompson, G.H.; Bradshaw, B.S. & Stern, M.P. (1994). Birthweight and adult health outcomes in a biethnic population in the USA. Diabetologia, 37(6), 624-631. doi:10.1007/BF00403383 PMid:7926349 Voight, B.F.; Kudaravalli, S.; Wen, X. & Pritchard, J.K. (2006). A map of recent positive selection in the human genome. PLoS Biol, 4,e72. doi:10.1371/journal.pbio.0040072 PMid:16494531 PMCid:1382018 Waterland, R.A. & Jirtle, R.L. (2004). Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition, 20, 63-68. doi:10.1016/j.nut.2003.09.011 PMid:14698016 Waterland, R.A.; Lin, J.R.; Smith, C.A. & Jirtle, R.L. (2006). Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet, 15(5), 705-716. doi:10.1093/hmg/ddi484 PMid:16421170 Waterland, RA. (2006). Epigenetic mechanisms and gastrointestinal development. J Pediatr, 149, s137-s142. doi:10.1016/j.jpeds.2006.06.064 PMid:17212956 Weaver, I.C.; Cervoni, N.; Champagne, F.A.; D'Alessio, A.C.; Sharma, S.; Seckl, J.R.; Dymov, S.; Szyf, M. & Meaney, M.J. (2004). Epigenetic programming by maternal behavior. Nat Neurosci, 7, 847-854. doi:10.1038/nn1276 PMid:15220929 Wong, A.; Gottesman, I. & Petronis, A. (2005). Phenotypic differences in genetically identical organism: the epigenetic perspective. Human Molecular Genetics, 14, R11-R18. doi:10.1093/hmg/ddi116 PMid:15809262 Wren, J. & Garner, H. (2005). Data-mining analysis suggests an epigenetic pathogenesis for type 2 diabetes. Journal of Biomedicine and Biotechnology, 2, 104-112. doi:10.1155/JBB.2005.104 PMid:16046815 PMCid:1184044 Xu, M.; Li, X.; Wang, J.G.; Du, P.; Hong, J.; Gu, W.; Zhang, Y. & Ning, G. (2005). Glucose and lipid metabolism in relation to novel polymorphisms in the 5’-AMP-activated protein kinase γ gene in Chinese. Molecular Genetics and Metabolism, 86, 372-378. doi:10.1016/j.ymgme.2005.06.012 PMid:16115789 Yamaoka, K. & Tango, T. (2005). Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care, 28(11), 2780-2786. doi:10.2337/diacare.28.11.2780 PMid:16249558 Yokomori, N.; Tawata, M. & Onaya, T. (1999). DNA demethylation during the differentiation of 3T3–L1 cells affects the expression of the mouse GLUT4 gene. Diabetes, 48, 685-690. doi:10.2337/diabetes.48.4.685 PMid:10102682 Zimmet, P.; Dowse, G. & Finch, C. (1990). The epidemiology and natural history of NIDDM—lessons from the South Pacific. Diabetes Metab Rev, 6, 91-124. doi:10.1002/dmr.5610060203 PMid:2198152 Zimmet, P.; Faaisu, S.; Ainuu, J.; Whitehouse, S.; Milne. B. & DeBoer, W. (1981). The prevalence of diabetes in the rural and urban populations of Western Samoa. Diabetes, 30, 45-51. doi:10.2337/diabetes.30.1.45 PMid:7227656 Zimmet, P.; Seluka, A.; Collins, J.; Currie, P.; Wicking, J. & DeBoer, W. (1977). Diabetes mellitus in an urbanized, isolated Polynesian population: The Funafuti survey. Diabetes, 26, 1101-1108. doi:10.2337/diabetes.26.12.1101 PMid:590635 ---------------------------------------------------------------------
